Commentary on Oeckl et al., "Serum Beta-Synuclein Is Higher in Down Syndrome and Precedes Rise of pTau181"

Ann Neurol. 2022 Jul;92(1):3-5. doi: 10.1002/ana.26414. Epub 2022 Jun 2.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural
  • Comment

MeSH terms

  • Alzheimer Disease*
  • Down Syndrome*
  • Humans
  • beta-Synuclein

Substances

  • beta-Synuclein